[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Transdermal Drug Delivery System Market Size, Manufacturers, Opportunities and Forecast to 2030

April 2024 | 114 pages | ID: G81D35EA28C6EN
APO Research

US$ 3,450.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

According to APO Research, The global Transdermal Drug Delivery System market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Transdermal Drug Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Transdermal Drug Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Transdermal Drug Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Transdermal Drug Delivery System include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku and Bayer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery System.

The Transdermal Drug Delivery System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Hisamitsu
  • Mylan
  • GSK
  • Novartis
  • Teve (Actavis)
  • Johnson & Johnson
  • Lohmann
  • Teikoku Seiyaku
  • Bayer
  • Lingrui
  • Sanofi
  • Qizheng
  • Endo
  • Huarun 999
  • Haw Par
  • Nichiban
  • Mentholatum
  • Laboratoires Genevrier
Transdermal Drug Delivery System segment by Type
  • Fentanyl
  • Nitroglycerin
  • Estradiol
  • Nicotine
  • Other
Transdermal Drug Delivery System segment by Application
  • OTC
  • Rx
Transdermal Drug Delivery System Segment by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • China Taiwan
    • Indonesia
    • Thailand
    • Malaysia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Drug Delivery System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Transdermal Drug Delivery System companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Transdermal Drug Delivery System Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Transdermal Drug Delivery System Market Size by Region (2019-2030)
  1.4.1 Global Transdermal Drug Delivery System Market Size by Region (2019-2024)
  1.4.2 Global Transdermal Drug Delivery System Market Size by Region (2025-2030)
1.5 Key Regions Transdermal Drug Delivery System Market Size (2019-2030)
  1.5.1 North America Transdermal Drug Delivery System Market Size Growth Rate (2019-2030)
  1.5.2 Europe Transdermal Drug Delivery System Market Size Growth Rate (2019-2030)
  1.5.3 Asia-Pacific Transdermal Drug Delivery System Market Size Growth Rate (2019-2030)
  1.5.4 Latin America Transdermal Drug Delivery System Market Size Growth Rate (2019-2030)
  1.5.5 Middle East & Africa Transdermal Drug Delivery System Market Size Growth Rate (2019-2030)

2 TRANSDERMAL DRUG DELIVERY SYSTEM MARKET BY TYPE

2.1 Type Introduction
  2.1.1 Fentanyl
  2.1.2 Nitroglycerin
  2.1.3 Estradiol
  2.1.4 Nicotine
  2.1.5 Other
2.2 Global Transdermal Drug Delivery System Market Size by Type
  2.2.1 Global Transdermal Drug Delivery System Market Size Overview by Type (2019-2030)
  2.2.2 Global Transdermal Drug Delivery System Historic Market Size Review by Type (2019-2024)
  2.2.3 Global Transdermal Drug Delivery System Market Size Forecasted by Type (2025-2030)
2.3 Global Transdermal Drug Delivery System Market Size by Regions
  2.3.1 North America Transdermal Drug Delivery System Market Size Breakdown by Type (2019-2024)
  2.3.2 Europe Transdermal Drug Delivery System Market Size Breakdown by Type (2019-2024)
  2.3.3 Asia-Pacific Transdermal Drug Delivery System Market Size Breakdown by Type (2019-2024)
  2.3.4 Latin America Transdermal Drug Delivery System Market Size Breakdown by Type (2019-2024)
  2.3.5 Middle East and Africa Transdermal Drug Delivery System Market Size Breakdown by Type (2019-2024)

3 TRANSDERMAL DRUG DELIVERY SYSTEM MARKET BY APPLICATION

3.1 Type Introduction
  3.1.1 OTC
  3.1.2 Rx
3.2 Global Transdermal Drug Delivery System Market Size by Application
  3.2.1 Global Transdermal Drug Delivery System Market Size Overview by Application (2019-2030)
  3.2.2 Global Transdermal Drug Delivery System Historic Market Size Review by Application (2019-2024)
  3.2.3 Global Transdermal Drug Delivery System Market Size Forecasted by Application (2025-2030)
3.3 Global Transdermal Drug Delivery System Market Size by Regions
  3.3.1 North America Transdermal Drug Delivery System Market Size Breakdown by Application (2019-2024)
  3.3.2 Europe Transdermal Drug Delivery System Market Size Breakdown by Application (2019-2024)
  3.3.3 Asia-Pacific Transdermal Drug Delivery System Market Size Breakdown by Application (2019-2024)
  3.3.4 Latin America Transdermal Drug Delivery System Market Size Breakdown by Application (2019-2024)
  3.3.5 Middle East and Africa Transdermal Drug Delivery System Market Size Breakdown by Application (2019-2024)

4 GLOBAL MARKET DYNAMICS

4.1 Transdermal Drug Delivery System Industry Trends
4.2 Transdermal Drug Delivery System Industry Drivers
4.3 Transdermal Drug Delivery System Industry Opportunities and Challenges
4.4 Transdermal Drug Delivery System Industry Restraints

5 COMPETITIVE INSIGHTS BY COMPANY

5.1 Global Top Players by Transdermal Drug Delivery System Revenue (2019-2024)
5.2 Global Transdermal Drug Delivery System Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Transdermal Drug Delivery System Key Company Headquarters & Area Served
5.4 Global Transdermal Drug Delivery System Company, Product Type & Application
5.5 Global Transdermal Drug Delivery System Company Commercialization Time
5.6 Market Competitive Analysis
  5.6.1 Global Transdermal Drug Delivery System Market CR5 and HHI
  5.6.2 Global Top 5 and 10 Transdermal Drug Delivery System Players Market Share by Revenue in 2023
  5.6.3 2023 Transdermal Drug Delivery System Tier 1, Tier 2, and Tier

6 COMPANY PROFILES

6.1 Hisamitsu
  6.1.1 Hisamitsu Comapny Information
  6.1.2 Hisamitsu Business Overview
  6.1.3 Hisamitsu Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.1.4 Hisamitsu Transdermal Drug Delivery System Product Portfolio
  6.1.5 Hisamitsu Recent Developments
6.2 Mylan
  6.2.1 Mylan Comapny Information
  6.2.2 Mylan Business Overview
  6.2.3 Mylan Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.2.4 Mylan Transdermal Drug Delivery System Product Portfolio
  6.2.5 Mylan Recent Developments
6.3 GSK
  6.3.1 GSK Comapny Information
  6.3.2 GSK Business Overview
  6.3.3 GSK Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.3.4 GSK Transdermal Drug Delivery System Product Portfolio
  6.3.5 GSK Recent Developments
6.4 Novartis
  6.4.1 Novartis Comapny Information
  6.4.2 Novartis Business Overview
  6.4.3 Novartis Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.4.4 Novartis Transdermal Drug Delivery System Product Portfolio
  6.4.5 Novartis Recent Developments
6.5 Teve (Actavis)
  6.5.1 Teve (Actavis) Comapny Information
  6.5.2 Teve (Actavis) Business Overview
  6.5.3 Teve (Actavis) Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.5.4 Teve (Actavis) Transdermal Drug Delivery System Product Portfolio
  6.5.5 Teve (Actavis) Recent Developments
6.6 Johnson & Johnson
  6.6.1 Johnson & Johnson Comapny Information
  6.6.2 Johnson & Johnson Business Overview
  6.6.3 Johnson & Johnson Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.6.4 Johnson & Johnson Transdermal Drug Delivery System Product Portfolio
  6.6.5 Johnson & Johnson Recent Developments
6.7 Lohmann
  6.7.1 Lohmann Comapny Information
  6.7.2 Lohmann Business Overview
  6.7.3 Lohmann Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.7.4 Lohmann Transdermal Drug Delivery System Product Portfolio
  6.7.5 Lohmann Recent Developments
6.8 Teikoku Seiyaku
  6.8.1 Teikoku Seiyaku Comapny Information
  6.8.2 Teikoku Seiyaku Business Overview
  6.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Product Portfolio
  6.8.5 Teikoku Seiyaku Recent Developments
6.9 Bayer
  6.9.1 Bayer Comapny Information
  6.9.2 Bayer Business Overview
  6.9.3 Bayer Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.9.4 Bayer Transdermal Drug Delivery System Product Portfolio
  6.9.5 Bayer Recent Developments
6.10 Lingrui
  6.10.1 Lingrui Comapny Information
  6.10.2 Lingrui Business Overview
  6.10.3 Lingrui Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.10.4 Lingrui Transdermal Drug Delivery System Product Portfolio
  6.10.5 Lingrui Recent Developments
6.11 Sanofi
  6.11.1 Sanofi Comapny Information
  6.11.2 Sanofi Business Overview
  6.11.3 Sanofi Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.11.4 Sanofi Transdermal Drug Delivery System Product Portfolio
  6.11.5 Sanofi Recent Developments
6.12 Qizheng
  6.12.1 Qizheng Comapny Information
  6.12.2 Qizheng Business Overview
  6.12.3 Qizheng Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.12.4 Qizheng Transdermal Drug Delivery System Product Portfolio
  6.12.5 Qizheng Recent Developments
6.13 Endo
  6.13.1 Endo Comapny Information
  6.13.2 Endo Business Overview
  6.13.3 Endo Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.13.4 Endo Transdermal Drug Delivery System Product Portfolio
  6.13.5 Endo Recent Developments
6.14 Huarun
  6.14.1 Huarun 999 Comapny Information
  6.14.2 Huarun 999 Business Overview
  6.14.3 Huarun 999 Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.14.4 Huarun 999 Transdermal Drug Delivery System Product Portfolio
  6.14.5 Huarun 999 Recent Developments
6.15 Haw Par
  6.15.1 Haw Par Comapny Information
  6.15.2 Haw Par Business Overview
  6.15.3 Haw Par Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.15.4 Haw Par Transdermal Drug Delivery System Product Portfolio
  6.15.5 Haw Par Recent Developments
6.16 Nichiban
  6.16.1 Nichiban Comapny Information
  6.16.2 Nichiban Business Overview
  6.16.3 Nichiban Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.16.4 Nichiban Transdermal Drug Delivery System Product Portfolio
  6.16.5 Nichiban Recent Developments
6.17 Mentholatum
  6.17.1 Mentholatum Comapny Information
  6.17.2 Mentholatum Business Overview
  6.17.3 Mentholatum Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.17.4 Mentholatum Transdermal Drug Delivery System Product Portfolio
  6.17.5 Mentholatum Recent Developments
6.18 Laboratoires Genevrier
  6.18.1 Laboratoires Genevrier Comapny Information
  6.18.2 Laboratoires Genevrier Business Overview
  6.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Revenue, Global Share and Gross Margin (2019-2024)
  6.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Product Portfolio
  6.18.5 Laboratoires Genevrier Recent Developments

7 NORTH AMERICA

7.1 North America Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Transdermal Drug Delivery System Market Size by Country (2019-2024)
7.3 North America Transdermal Drug Delivery System Market Size Forecast by Country (2025-2030)

8 EUROPE

8.1 Europe Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Transdermal Drug Delivery System Market Size by Country (2019-2024)
8.3 Europe Transdermal Drug Delivery System Market Size Forecast by Country (2025-2030)

9 ASIA-PACIFIC

9.1 Asia-Pacific Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2019-2024)
9.3 Asia-Pacific Transdermal Drug Delivery System Market Size Forecast by Country (2025-2030)

10 LATIN AMERICA

10.1 Latin America Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Transdermal Drug Delivery System Market Size by Country (2019-2024)
10.3 Latin America Transdermal Drug Delivery System Market Size Forecast by Country (2025-2030)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2019-2024)
11.3 Middle East & Africa Transdermal Drug Delivery System Market Size Forecast by Country (2025-2030)

12 CONCLUDING INSIGHTS

13 APPENDIX

13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
  13.5.1 Secondary Sources
  13.5.2 Primary Sources

LIST OF TABLES

Table 1. Global Transdermal Drug Delivery System Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Transdermal Drug Delivery System Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Transdermal Drug Delivery System Market Share by Region (2019-2024)
Table 4. Global Transdermal Drug Delivery System Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Transdermal Drug Delivery System Market Share by Region (2025-2030)
Table 6. Global Transdermal Drug Delivery System Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Transdermal Drug Delivery System Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Transdermal Drug Delivery System Market Size Share by Type (2019-2024)
Table 9. Global Transdermal Drug Delivery System Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Transdermal Drug Delivery System Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Transdermal Drug Delivery System Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Transdermal Drug Delivery System Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Transdermal Drug Delivery System Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Transdermal Drug Delivery System Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Transdermal Drug Delivery System Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Transdermal Drug Delivery System Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Transdermal Drug Delivery System Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Transdermal Drug Delivery System Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Transdermal Drug Delivery System Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Transdermal Drug Delivery System Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Transdermal Drug Delivery System Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Transdermal Drug Delivery System Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Transdermal Drug Delivery System Market Size Share by Application (2019-2024)
Table 24. Global Transdermal Drug Delivery System Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Transdermal Drug Delivery System Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Transdermal Drug Delivery System Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Transdermal Drug Delivery System Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Transdermal Drug Delivery System Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Transdermal Drug Delivery System Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Transdermal Drug Delivery System Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Transdermal Drug Delivery System Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Transdermal Drug Delivery System Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Transdermal Drug Delivery System Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Transdermal Drug Delivery System Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Transdermal Drug Delivery System Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Transdermal Drug Delivery System Industry Trends
Table 37. Transdermal Drug Delivery System Industry Drivers
Table 38. Transdermal Drug Delivery System Industry Opportunities and Challenges
Table 39. Transdermal Drug Delivery System Industry Restraints
Table 40. Global Transdermal Drug Delivery System Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Transdermal Drug Delivery System Revenue Market Share by Company (2019-2024)
Table 42. Global Transdermal Drug Delivery System Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Transdermal Drug Delivery System Key Company Headquarters & Area Served
Table 44. Global Transdermal Drug Delivery System Company, Product Type & Application
Table 45. Global Transdermal Drug Delivery System Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Transdermal Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. Hisamitsu Business Overview
Table 49. Hisamitsu Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. Hisamitsu Transdermal Drug Delivery System Product Portfolio
Table 51. Hisamitsu Recent Development
Table 52. Mylan Company Information
Table 53. Mylan Business Overview
Table 54. Mylan Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Mylan Transdermal Drug Delivery System Product Portfolio
Table 56. Mylan Recent Development
Table 57. GSK Company Information
Table 58. GSK Business Overview
Table 59. GSK Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. GSK Transdermal Drug Delivery System Product Portfolio
Table 61. GSK Recent Development
Table 62. Novartis Company Information
Table 63. Novartis Business Overview
Table 64. Novartis Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. Novartis Transdermal Drug Delivery System Product Portfolio
Table 66. Novartis Recent Development
Table 67. Teve (Actavis) Company Information
Table 68. Teve (Actavis) Business Overview
Table 69. Teve (Actavis) Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Teve (Actavis) Transdermal Drug Delivery System Product Portfolio
Table 71. Teve (Actavis) Recent Development
Table 72. Johnson & Johnson Company Information
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Johnson & Johnson Transdermal Drug Delivery System Product Portfolio
Table 76. Johnson & Johnson Recent Development
Table 77. Lohmann Company Information
Table 78. Lohmann Business Overview
Table 79. Lohmann Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Lohmann Transdermal Drug Delivery System Product Portfolio
Table 81. Lohmann Recent Development
Table 82. Teikoku Seiyaku Company Information
Table 83. Teikoku Seiyaku Business Overview
Table 84. Teikoku Seiyaku Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Teikoku Seiyaku Transdermal Drug Delivery System Product Portfolio
Table 86. Teikoku Seiyaku Recent Development
Table 87. Bayer Company Information
Table 88. Bayer Business Overview
Table 89. Bayer Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Bayer Transdermal Drug Delivery System Product Portfolio
Table 91. Bayer Recent Development
Table 92. Lingrui Company Information
Table 93. Lingrui Business Overview
Table 94. Lingrui Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. Lingrui Transdermal Drug Delivery System Product Portfolio
Table 96. Lingrui Recent Development
Table 97. Sanofi Company Information
Table 98. Sanofi Business Overview
Table 99. Sanofi Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. Sanofi Transdermal Drug Delivery System Product Portfolio
Table 101. Sanofi Recent Development
Table 102. Qizheng Company Information
Table 103. Qizheng Business Overview
Table 104. Qizheng Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 105. Qizheng Transdermal Drug Delivery System Product Portfolio
Table 106. Qizheng Recent Development
Table 107. Endo Company Information
Table 108. Endo Business Overview
Table 109. Endo Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 110. Endo Transdermal Drug Delivery System Product Portfolio
Table 111. Endo Recent Development
Table 112. Huarun 999 Company Information
Table 113. Huarun 999 Business Overview
Table 114. Huarun 999 Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 115. Huarun 999 Transdermal Drug Delivery System Product Portfolio
Table 116. Huarun 999 Recent Development
Table 117. Haw Par Company Information
Table 118. Haw Par Business Overview
Table 119. Haw Par Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 120. Haw Par Transdermal Drug Delivery System Product Portfolio
Table 121. Haw Par Recent Development
Table 122. Nichiban Company Information
Table 123. Nichiban Business Overview
Table 124. Nichiban Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 125. Nichiban Transdermal Drug Delivery System Product Portfolio
Table 126. Nichiban Recent Development
Table 127. Mentholatum Company Information
Table 128. Mentholatum Business Overview
Table 129. Mentholatum Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 130. Mentholatum Transdermal Drug Delivery System Product Portfolio
Table 131. Mentholatum Recent Development
Table 132. Laboratoires Genevrier Company Information
Table 133. Laboratoires Genevrier Business Overview
Table 134. Laboratoires Genevrier Transdermal Drug Delivery System Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 135. Laboratoires Genevrier Transdermal Drug Delivery System Product Portfolio
Table 136. Laboratoires Genevrier Recent Development
Table 137. North America Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 138. North America Transdermal Drug Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 139. North America Transdermal Drug Delivery System Market Share by Country (2019-2024)
Table 140. North America Transdermal Drug Delivery System Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 141. North America Transdermal Drug Delivery System Market Share Forecast by Country (2025-2030)
Table 142. Europe Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 143. Europe Transdermal Drug Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 144. Europe Transdermal Drug Delivery System Market Share by Country (2019-2024)
Table 145. Europe Transdermal Drug Delivery System Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 146. Europe Transdermal Drug Delivery System Market Share Forecast by Country (2025-2030)
Table 147. Asia-Pacific Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 148. Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 149. Asia-Pacific Transdermal Drug Delivery System Market Share by Country (2019-2024)
Table 150. Asia-Pacific Transdermal Drug Delivery System Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 151. Asia-Pacific Transdermal Drug Delivery System Market Share Forecast by Country (2025-2030)
Table 152. Latin America Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 153. Latin America Transdermal Drug Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 154. Latin America Transdermal Drug Delivery System Market Share by Country (2019-2024)
Table 155. Latin America Transdermal Drug Delivery System Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 156. Latin America Transdermal Drug Delivery System Market Share Forecast by Country (2025-2030)
Table 157. Middle East & Africa Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 158. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 159. Middle East & Africa Transdermal Drug Delivery System Market Share by Country (2019-2024)
Table 160. Middle East & Africa Transdermal Drug Delivery System Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 161. Middle East & Africa Transdermal Drug Delivery System Market Share Forecast by Country (2025-2030)
Table 162. Research Programs/Design for This Report
Table 163. Authors List of This Report
Table 164. Secondary Sources
Table 165. Primary Sources

LIST OF FIGURES

Figure 1. Transdermal Drug Delivery System Product Picture
Figure 2. Global Transdermal Drug Delivery System Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Transdermal Drug Delivery System Market Size (2019-2030) & (US$ Million)
Figure 4. Global Transdermal Drug Delivery System Market Share by Region: 2023 VS 2030
Figure 5. Global Transdermal Drug Delivery System Market Share by Region (2019-2030)
Figure 6. North America Transdermal Drug Delivery System Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Transdermal Drug Delivery System Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Transdermal Drug Delivery System Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Transdermal Drug Delivery System Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Transdermal Drug Delivery System Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Fentanyl
Figure 12. Global Fentanyl Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Nitroglycerin
Figure 14. Global Nitroglycerin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of Estradiol
Figure 16. Global Estradiol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Product Picture of Nicotine
Figure 18. Global Nicotine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Product Picture of Other
Figure 20. Global Other Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Global Transdermal Drug Delivery System Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 22. Global Transdermal Drug Delivery System Market Share by Type 2023 VS 2030
Figure 23. North America Transdermal Drug Delivery System Market Size Share by Type (2019-2030)
Figure 24. Europe Transdermal Drug Delivery System Market Size Share by Type (2019-2030)
Figure 25. Asia-Pacific Transdermal Drug Delivery System Market Size Share by Type (2019-2030)
Figure 26. Latin America Transdermal Drug Delivery System Market Size Share by Type (2019-2030)
Figure 27. Middle East and Africa Transdermal Drug Delivery System Market Size Share by Type (2019-2030)
Figure 28. Product Picture of OTC
Figure 29. Global OTC Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Product Picture of Rx
Figure 31. Global Rx Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Global Transdermal Drug Delivery System Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 33. Global Transdermal Drug Delivery System Market Share by Application 2023 VS 2030
Figure 34. North America Transdermal Drug Delivery System Market Size Share by Application (2019-2030)
Figure 35. Europe Transdermal Drug Delivery System Market Size Share by Application (2019-2030)
Figure 36. Asia-Pacific Transdermal Drug Delivery System Market Size Share by Application (2019-2030)
Figure 37. Latin America Transdermal Drug Delivery System Market Size Share by Application (2019-2030)
Figure 38. Middle East and Africa Transdermal Drug Delivery System Market Size Share by Application (2019-2030)
Figure 39. Global Top 5 and 10 Transdermal Drug Delivery System Players Market Share by Revenue in 2023
Figure 40. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 41. North America Transdermal Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 42. North America Transdermal Drug Delivery System Market Share by Country: 2019 VS 2023 VS 2030
Figure 43. North America Transdermal Drug Delivery System Market Share by Country (2019-2030)
Figure 44. Europe Transdermal Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 45. Europe Transdermal Drug Delivery System Market Share by Country: 2019 VS 2023 VS 2030
Figure 46. Europe Transdermal Drug Delivery System Market Share by Country (2019-2030)
Figure 47. Asia-Pacific Transdermal Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. Asia-Pacific Transdermal Drug Delivery System Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Transdermal Drug Delivery System Market Share by Country (2019-2030)
Figure 50. Latin America Transdermal Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Latin America Transdermal Drug Delivery System Market Share by Country: 2019 VS 2023 VS 2030
Figure 52. Latin America Transdermal Drug Delivery System Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Transdermal Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Middle East & Africa Transdermal Drug Delivery System Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Middle East & Africa Transdermal Drug Delivery System Market Share by Country (2019-2030)
Figure 56. Years Considered
Figure 57. Research Process
Figure 58. Key Executives Interviewed


More Publications